Cellectar Biosciences, Inc. — Director's Dealing 2019

Jun 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2019-06-13

Reporting Person: Loren Stefan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-13	Stock option (right to buy)	$2.15	A	6500	Acquired	2029-06-13	Common Stock (6500)	Direct

Footnotes

F1: Options vest on the one year anniversary of the date of grant.